Portuguese water dogs, Shiba Inn dogs and Alaskan huskies. The molecular defects responsible for GM1-gangliosidosis in dogs
were described only for the last three breeds [4, 16, 17, 18] . Thus, in Portuguese water dogs with GM1-gangliosidosis exon 2 of GLB1 gene is mutated, while for Shiba dogs the mutation occurs in exon 15 [16, 18] . In Shiba dogs the disease is milder than the late infantile GM1-gangliosidosis in humans with slightly later onset and longer survival period [3, 8, 16] . In the present study, we describe at the molecular level a canine Alaskan husky model for the late infantile type II GM1-gangliosidosis. 15 , which generates a premature termination codon [4, 17] . [14, 17] . Clinically, the first disease signs are present at [6] [7] [8] [13, 14, 17] .
The genetic defect in Alaskan huskies with GM1-gangliosidosis is represented by a 19 bp duplication, in exon 15 of the canine GLB1 gene, which partially disrupts a potential exon splicing enhancer (ESE) leading to exon 15 skipping in a fraction of the transcripts. The other transcripts retained the mutated exon

As a result of these genetic modification a severe deficiency in the GLB1 enzymatic activity (only 1-10% compared to homozygous healthy dogs) can be found and results in a massive accumulation of GM1-gangliosides in various cells especially in neurons of the central nervous system in affected homozygous individuals
weeks after birth and progressed steadily until death of the affected individuals at the 9-12 months of age. The diseased animals show signs of progressive cerebellar dysfunctions including ataxia and spasticity similar to those observed in humans with late infantile GM1-gangliosidosis
Like all lysosomal enzymes, human GLB1 is transported to its final destination along the secretory pathways [19, 20] . Thus, the 84 kDa human GLB1 precursor synthesized on ribosomes contains an N-terminal signal sequence (ss) which targets its co-translational translocation in the endoplasmic reticulum (ER) [21, 22] . After the proteolytic cleavage of this signal sequence, the nascent protein undergoes glycosylation in the ER and further in Golgi compartments [23, 24] . Subsequently, the precursor protein is phosphorylated and mannose-6-phosphate targeted to the lysosomes [20, 25] . Here, in an acidic environment, the human GLB1 precursor protein is processed to a mature enzyme by proteolytic modification at the C-terminal region. The resulting proteolytic fragments (64 and 22 kDa) generate the fully active GLB1 [26] . Finally, the 64 kDa fragment of GLB1 is degraded to an 18 and respectively 50 kDa fragments by cathepsin-B like thiol proteases [24] Along these secretory pathways, the human GLB1 forms complexes with protective protein/ cathepsin A (PPCA) and N-acetyl-␣-neuraminidase (NEU.1; EC 3.2.1.18) which are essential for intracellular routing and maintenance of GLB1 activity [26, 27] . Without PPCA, human GLB1 is abnormally cleaved to inactive 80 and 72 kDa peptides [24] .
For a better understanding of the molecular mechanisms underlying GM1-gangliosidosis in both the canine disease and human late infantile type II form, the present study focused on the analysis of the molecular events which connect the genetic defects to the lack of GLB1 activity. Therefore, the possible association between the absence of GLB1 activity and the abnormal processing of the canine GLB1 mutants or impaired transport to the lysosomes was investigated. This was accomplished by following the GLB1 proteins from the synthesis on the ribosomes until their final destination, the lysosomes.
Materials and methods
Computer-aided analyses
The canine N-terminal signal sequence necessary for GLB1 translocation into the ER was predicted using the SignalP 3.0 software [28, 29] . To identify the putative N-linked glycosylation sites the amino acid sequence of GLB1 was screened with the NetNGlyc software [30] . The Protein Calculator v3. 3 . was used to estimate the molecular weight of the proteins. 
RNA isolation and cDNA synthesis
GLB1 enzymatic assays
GLB1 activity was measured using 4-methylumbelliferyl-␤-D-galactopyranoside (4-MU-G, Sigma-Aldrich, Taufkirchen, Germany) as previously described [14, [31] [32] [33] .
Briefly, GLB1 cleaves 4-MU-G to galactose and the fluorescent compound (4-MU). The 4-MU released is measured at 365 nm and 455 nm and the GLB1 activity is given in mU/mg protein. Fibroblasts from Alaskan huskies GLB1 +/+ dogs were used as positive controls.
Normalization of GLB1 activities
The GLB1 activities were normalized by using the amount of total protein and transfection efficiency.
The transfection efficiencies were expressed as the percentage of ECFP-expressing cells [(ECFP-expressing cells / total number of cells) ϫ 100]. Then, the GLB1 activity of the transfected cells was extrapolated to 100% of transfection efficiency. For detection of GLB1 activity in transfected and non-transfected cells, the same number of cells was used. Finally, the GLB1 activity was presented as mU/mg total protein.
All experiments were performed in triplicates. Fig. 5A; line 2) , nor to the 20 kD fragment ( Fig. 5B; 
SDS/PAGE and immunoblotting
locus. To examine whether this fragment is generated by lysosomal processing, a canine GLB1 protein designed to be retained in the ER was also analysed (ss-ECFP-(+iss)-GLB1). This protein showed neither processing to the 90 and 44 kD fragments (
line 2). This result confirmed the lysosomal origin of the 20 kD fragment. To further determine whether possible processing differences between the wild type and the mutant proteins are responsible for the lack of the GLB1 activity in the
Fig. 2 Localization of ECFP and ss-ECFP proteins in MDCK cells, 24 hrs after transfection; A: uniform cytoplasmic distribution of ECFP protein; B: endoplasmic reticulum and Golgi apparatus (arrows) distribution of ss-ECFP protein.
Fig. 3 Influence of ECFP and His tag on canine GLB1 activity in MDCK cells, GLB1 -/ -and GLB1+/+ fibroblasts; the data shown that GLB1 activity (mU/mg) increased after transfection with the wild-type GLB1 containing vectors, while no difference in GLB1 activity was detected between those cells transfected with ss-(-iss)-GLB1-His or ss-ECFP-(-iss)-GLB1-His vectors; non-transfected -endogenous GLB1 activity in MDCK cells, GLB1
-/-and GLB1 +/+ fibroblasts; (Fig. 7A and B Fig. 8A; lines 1,2 and 3) . In contrast, the C-terminal processing of the mutant proteins differed from the wild type protein as assessed by variations in the small polypeptide bands, 20 kD for the wild type protein (Figure 8 B; line 1) compared to a 11 kD for the GLB1delEx15 (Fig. 8B; line 2) and no polypeptide for the GLB1-19bpdupl mutant ( Fig. 8B; line 3) . Figure 5B 
ss-ECFP -GLB1 activity in cells transfected with the ss-ECFP construct; ss-(-iss)-GLB1 -GLB1 activity in cells transfected with the wild-type GLB1 without ECFP and His tag; ss-ECFP-(-iss)-GLB1-His -GLB1 activity in cells transfected with the construct containing a signal sequence (ss) for internalization into the ER, before ECFP sequence and the wild-type GLB1 without its signal sequence (-iss), fused to 6xHis at C-terminus. homozygous individuals carrying the 19 bp duplication, the intracellular routing and the processing of the mutant proteins was investigated. MDCK cells and GLB1 -/-fibroblasts were transfected with ss-ECFP-(-iss)-GLB1delEx15-His and ss-ECFP-(-iss)-GLB1-19bpdupl-His vectors. In comparison with the wild type GLB1 protein, the mutant GLB1 proteins were inactive (Fig. 6). Moreover, the intracellular localization of these mutant proteins was observed by confocal microscopy after specific staining of the lysosomes with LysoTracker. For this purpose, MDCK cells were transfected with ss-ECFP-(-iss)-GLB1delEx15-His and ss-ECFP-(-iss)-GLB1-19bpdupl-His vectors. As the wild type protein, a fraction of the mutant proteins was also located in the lysosomes
Fig. 4 Localization of wild-type canine GLB1 in MDCK cells transfected with ss-ECFP-(-iss)-GLB1-His construct; confocal microscopy analyses revealed the lysosomal localization of wild-type GLB1; I, lysosomes stained with LysoTracker (red); II, wild-type canine GLB1 detected by ECFP fluorescence (green); III, co-localization of LysoTracker and GLB1 (amber); magnification 630ϫ.
Fig. 5 Processing of wild-type ECFP fused GLB1 in MDCK cells; the Western blot images shown the lysosomal maturation of wild-type GLB1 as indicated by the presence of the 90 kD (A, line 1) and 20 kD (B, line1) bands, in comparison with the ER resident GLB1 protein (A, B, lines 2) (A) 110 kD canine GLB1 precursor protein (84 kD precursor GLB1 + 26 kD ECFP), 90 kD processed fragment (64 kD mature GLB1 + 26 kD ECFP) and 44 kD fragment (18 kD GLB1 fragment + 26 kD ECFP) were detected using anti-ECFP antibody; (B) 110 kD canine GLB1 precursor protein (84 kD precursor GLB1 + 26 kD ECFP) and 20 kD polypeptide was observed using antiHis-antibody; an unspecific band of ~40 kD appeared in
Discussion
In the present study, the intracellular localization, processing, and enzymatic activity of the wild type and two mutant GLB1 proteins were investigated in a canine model of GM1-gangliosidosis with the ultimate goal to elucidate the patho-mechanism of GM1-gangliosidosis [4, 14] .
Using clinical and biochemical data it was demonstrated that GM1-gangliosidosis in dogs resembled its human counterpart to a higher extent than GM1-gangliosidosis in genetically engineered mice [12, 16, [35] [36] [37] 
. Unlike in humans, a regulatory mechanism in the murine brain involving an active desialylating enzyme reduces the GM1-ganglioside accumulation thus leading to high levels of asialo-GM1 (GA1). In this model it is difficult to differentiate the phenotypic effects of GM1 from those of GA1 accumulation.
Moreover, due to this molecular system, high levels of GM1, typical for types I and II GM1-gangliosidosis are attained in genetically engineered mice only at an adult age [38] [39] [40] .
For further therapeutic approaches, the similarities between canine and human GLB1 were investigated at the molecular level. Furthermore, the role of canine GLB1 mutants in onset of GM1-gangliosidosis was also elucidated.
Firstly, structural features, lysosomal transport and maturation of canine GLB1 were investigated and compared to human GLB1. (N 542 S↓SNYT LPAFYMGGNPF 555 ) [22) [41] [42] [43] . Differences between immortalized and primary cells regarding senescence-associated GLB1 (wild type GLB1) activities were already described [44] . [45] [46] [47] . In view of the great similarity between the human and canine GLB1 it is plausible to propose a similar complex formation between GLB1 and PPCA with a comparable molecular ratio for the canine lysosomal multienzymic complex [18, 35] . 
Both enzymes have an identical cleavage sequence for proteolytic maturation in lysosomes
26]. This demonstrated that the canine GM1-gangliosidosis resembled its human counterpart not only at the clinical, but also at the molecular level. To determine whether the lack of GLB1 activity observed in affected dogs is the result of an abnormal transport through the cell or is a consequence of abnormal proteolytic processing of the C-terminus, the influence of two distinct genetic modifications in the GLB1 mRNA on the intracellular trafficking of the corresponding proteins was investigated. Both cell types analysed, MDCK cells and canine GLB1
GLB1 activity (mU/mg) increased after transfection with the wild type GLB1 containing vector, whereas in cells transfected with the constructs which encodes for mutant GLB1 proteins the GLB1 activity decreased under the levels of non-transfected cells. ss-ECFP -GLB1 activity in cells transfected with the ss-ECFP construct; ss-ECFP-(-iss)-GLB1-His -GLB1 activity in cells transfected with ss-ECFP-(-iss)-GLB1-His construct which encodes for the wildtype GLB1; ss-ECFP-(-iss)-GLB1delEx15-His -GLB1 activity in cells transfected with ss-ECFP-(-iss)-GLB1delEx15-His construct which encodes the mutant GLB1 without the sequence encoded by exon 15; ss-ECFP-(-iss)-GLB1-19bpdupl-His -GLB1 activity in cells transfected with ss-ECFP-(-iss)-GLB1-19bpdu-
Interestingly, when MDCK cells were transfected with ss-ECFP-(-iss)-GLB1delEx15 and ss-ECFP-(-iss)-GLB1-19bpdupl vectors
